Literature DB >> 23022920

Inappropriate use of the faecal occult blood test in a university hospital in the Netherlands.

Anne F van Rijn1, An K Stroobants, Marije Deutekom, Corinne Lauppe, Auguste Sturk, Patrick M M Bossuyt, Paul Fockens, Evelien Dekker.   

Abstract

OBJECTIVES: Although all international guidelines state that there is no indication to perform a faecal occult blood test (FOBT) in symptomatic patients, we believe the test is frequently used as a diagnostic test. The objective of this study was to investigate whether the current guidelines for FOBT use are being followed in the Netherlands.
METHODS: The frequency of reasons for ordering a FOBT in 15 hospitals over a time period of 1 year was determined and the consequences of the test result on the diagnostic workup were determined by a retrospective search of electronic hospital charts.
RESULTS: In 14 of the 15 hospitals a FOBT was available and totally 2993 FOBTs were performed in 1 year. A total of 201 electronic charts were retrieved. The FOBTs were ordered because of anaemia (41%), suspicion of rectal bleeding (17%), abdominal pain (14%), changed bowel habits (10%) or others (18%). A positive test result was found in 66 (33%) patients and a negative in 133 (66%). Respectively, 38% (25/66) of the patients with a positive and 41% (55/133) of the patients with a negative test result received a gastrointestinal follow-up investigation. In 25/80 investigations, a possible cause of rectal blood loss was detected, of which 13 had a positive FOBT result.
CONCLUSION: This study demonstrates that current guidelines on FOBT use are not followed in the Netherlands and that a FOBT is often used as a diagnostic tool instead of a screening tool, thereby causing confusion and unnecessary delays in the diagnostic workup of patients.

Entities:  

Mesh:

Year:  2012        PMID: 23022920     DOI: 10.1097/MEG.0b013e328313bbd3

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  8 in total

1.  Putting an end to the misuse of the fecal occult blood test in diagnostic medicine.

Authors:  Catherine Dubé
Journal:  Can J Gastroenterol       Date:  2013-12       Impact factor: 3.522

2.  Use of fecal occult blood testing in hospitalized patients: results of an audit.

Authors:  Stephen Ip; AbdulRazaq A H Sokoro; Lisa Kaita; Claudia Ruiz; Elaine McIntyre; Harminder Singh
Journal:  Can J Gastroenterol Hepatol       Date:  2014-10

3.  More on fecal occult blood test misuse.

Authors:  Clarence Wong; Catherine Dubé
Journal:  Can J Gastroenterol Hepatol       Date:  2014-09

4.  Five common errors to avoid in clinical practice: the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) Choosing Wisely Campaign.

Authors:  Elisa Stasi; Andrea Michielan; Gaetano Cristian Morreale; Alessandro Tozzi; Ludovica Venezia; Francesco Bortoluzzi; Omero Triossi; Marco Soncini; Gioacchino Leandro; Giuseppe Milazzo; Andrea Anderloni
Journal:  Intern Emerg Med       Date:  2018-11-29       Impact factor: 3.397

5.  Making FIT Count: Maximizing Appropriate Use of the Fecal Immunochemical Test for Colorectal Cancer Screening Programs.

Authors:  Vivy T Cusumano; Folasade P May
Journal:  J Gen Intern Med       Date:  2020-03-03       Impact factor: 5.128

6.  Fecal occult blood testing as a diagnostic test in symptomatic patients is not useful: a retrospective chart review.

Authors:  Neeraj Narula; Diana Ulic; Raed Al-Dabbagh; Ali Ibrahim; Maged Mansour; Cynthia Balion; John K Marshall
Journal:  Can J Gastroenterol Hepatol       Date:  2014-07-11

7.  Utilization of fecal occult blood test in the acute hospital setting and its impact on clinical management and outcomes.

Authors:  S Mosadeghi; H Ren; J Catungal; I Yen; B Liu; R J Wong; T Bhuket
Journal:  J Postgrad Med       Date:  2016 Apr-Jun       Impact factor: 1.476

8.  Use and abuse of fecal occult blood tests: a community hospital experience.

Authors:  Sarthak Soin; Olalekan Akanbi; Abdullah Ahmed; Yunha Kim; Sarbagya Pandit; Igor Wroblewski; Nasir Saleem
Journal:  BMC Gastroenterol       Date:  2019-09-03       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.